Search

James Camden Phones & Addresses

  • Cincinnati, OH
  • 145 Ashton Place Cir, Winston Salem, NC 27106 (336) 924-4199
  • 3820 Gulf Bch, Saint Pete Beach, FL 33706 (727) 367-8718
  • Saint Petersburg, FL
  • 33906 Americana Ave, Dade City, FL 33525 (352) 588-2822 (727) 367-8718
  • 7339 Charter Cup Ln, West Chester, OH 45069 (513) 779-9424
  • Butler, OH
  • Milford, OH
  • Pace, FL
  • Medway, OH
  • 3820 Gulf Blvd APT 1205, St Pete Beach, FL 33706 (727) 534-5392

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher

Specialities

Antitrust & Competition

Professional Records

License Records

James B Camden

Address:
33906 Americana Ave, Dade City, FL 33525
License #:
53739 - Expired
Category:
Engineers
Issued Date:
Feb 3, 1999
Effective Date:
Mar 14, 2017
Expiration Date:
Feb 28, 2017
Type:
Professional Engineer

Lawyers & Attorneys

James Camden Photo 1

James Camden - Lawyer

Office:
McDermott Will & Emery LLP
Specialties:
Antitrust & Competition
ISLN:
922038649
Admitted:
2009
University:
Duke University, B.S., 2006
Law School:
Washington University School of Law, J.D., 2009

Resumes

Resumes

James Camden Photo 2

James Camden

Location:
United States
James Camden Photo 3

James Camden

Business Records

Name / Title
Company / Classification
Phones & Addresses
James R Camden
JOHN V. HARMEYER, INC
Cincinnati, OH

Publications

Us Patents

Viral Treatment

US Patent:
6340696, Jan 22, 2002
Filed:
Sep 15, 2000
Appl. No.:
09/663578
Inventors:
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 3141
US Classification:
514361, 514 8, 514 25
Abstract:
A pharmaceutical composition that inhibits or slows the growth of viruses in animals, particularly in mammals, while reducing cytoxicity of ribavirin or interferon is disclosed. This same composition can be used to treat viral infections, particularly hepatitis C. The composition preferably comprises from about 10 mg to about 6000 mg of a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or (5-aryl-1,2,4-thiadiazol)-3-yl urea derivative of the formula: wherein X is oxygen or sulfur, R is hydrogen or alkyl having from 1-3 carbons, n is 0-4, R is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo or fluoro, oxychloro, alkoxy having the formula âO(CH ) CH , wherein y is from 1 to 6, or a pharmaceutically acceptable acid addition salt or prodrug thereof and a safe and effective amount of ribavirin, interferon or mixtures thereof. The preferred compound is (5-phenyl-1,2,4-thiadazol-3-yl) thiourea.

Methods Of Treating Viral Infections With Benzimidazoles

US Patent:
6362207, Mar 26, 2002
Filed:
Dec 22, 2000
Appl. No.:
09/748651
Inventors:
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 3153
US Classification:
514365, 514397, 514398, 424450, 424451, 424464, 424486
Abstract:
This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed. The benzimidazole derivative is selected from the group consisting of: wherein X is hydrogen, halogen, alkyl of less than 7 carbon atoms or alkoxy of less than 7 carbon atoms; n is a positive integer of less than 4; Y is hydrogen, chlorine, nitro, methyl, ethyl or oxychloro; R is hydrogen, alkylaminocarbonyl wherein the alkyl group has from 3 to 6 carbon atoms, or an alkyl group of from 1 to 8 carbon atoms and R is 4-thiazolyl, NHCOOR wherein R is aliphatic hydrocarbon of less than 7 carbon atoms, prodrugs, pharmaceutically acceptable salts and mixtures thereof and a pharmaceutically acceptable carrier.

Benzimidazole Urea Derivatives, And Pharmaceutical Compositions And Unit Dosages Thereof

US Patent:
6380232, Apr 30, 2002
Filed:
Sep 26, 2000
Appl. No.:
09/670170
Inventors:
Joseph K. Agyin - San Antonio TX
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 314184
US Classification:
514388, 5483074
Abstract:
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.

Cancer Treatment

US Patent:
6384049, May 7, 2002
Filed:
May 25, 2000
Appl. No.:
09/578281
Inventors:
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 3144
US Classification:
514303, 514 8, 514 12, 424450
Abstract:
This invention is a method of treating cancer, including carcinomas and sarcomas through the administration of a pharmaceutical composition containing a pyridinylimidazole carbamate. The pyridinylimidazole carbamate is selected from the group consisting of: wherein X is independently selected from the group consisting of halo, for example, bromo, fluoro, chloro, iodo; hydroxyl, alkyl of less than 8 carbon atoms or alkoxy of less than 8 carbon atoms; n is a positive integer less than 4; R is hydrogen or an alkyl group of from 1 to 8 carbons and its pharmaceutically acceptable salts and prodrugs thereof.

Viral Treatment

US Patent:
6384064, May 7, 2002
Filed:
May 30, 2001
Appl. No.:
09/871565
Inventors:
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 31433
US Classification:
514361
Abstract:
Methods for inhibiting viral infection are disclosed comprising adminstering a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or (5-aryl-1,2,4-thiadiazol)-3-yl urea derivative of the formula: wherein X is oxygen or sulfur, R is hydrogen or alkyl having from 1-3 carbons, n is 1-4, R is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo or fluoro, oxychloro, alkoxy having the formula âO(CH ) CH wherein y is from 1 to 6, or a pharmaceutically acceptable acid addition salt or prodrug thereof. The preferred compound is (5-phenyl-1,2,4-thiadazol-3-yl) thiourea.

Compounds And Methods For Use Thereof In The Treatment Of Cancer Or Viral Infections

US Patent:
6407105, Jun 18, 2002
Filed:
Sep 26, 2000
Appl. No.:
09/670169
Inventors:
Joseph K. Agyin - San Antonio TX
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 314184
US Classification:
5142345, 514388, 544139, 5483081, 5483084
Abstract:
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.

Compounds And Method For Use Thereof In The Treatment Of Cancer Or Viral Infections

US Patent:
6407131, Jun 18, 2002
Filed:
Sep 29, 2000
Appl. No.:
09/676030
Inventors:
Joseph K. Agyin - San Antonio TX
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 31415
US Classification:
514395
Abstract:
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.

Viral Treatment

US Patent:
6410575, Jun 25, 2002
Filed:
Mar 19, 2001
Appl. No.:
09/812094
Inventors:
James Berger Camden - West Chester OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 31433
US Classification:
514361
Abstract:
A pharmaceutical composition that inhibits or slows the growth of viruses in animals, particularly in mammals, is disclosed. This same composition is can be used to treat viral infections, particularly hepatitis C, herpes simplex, Kaposis sarcoma and HIV. The composition preferably comprises from about 10 mg to about 6000 mg of a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or of the formula: wherein X is sulfur, R is hydrogen or alkyl having from 1-3 carbons, n is 0-4, R is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo or fluoro, oxychloro, alkoxy having the formula âO(CH ) CH wherein y is from 1 to 6, or a pharmaceutically acceptable acid addition salt or prodrug thereof. The preferred compound is (5-phenyl-1,2,4-thiadazol-3-yl)thiourea.
James B Camden from Cincinnati, OH, age ~81 Get Report